lncRNA TUG1 promotes the development of oral squamous cell carcinoma by regulating the MAPK signaling pathway by sponging miR-593-3p

References

• Kumar M, Nanavati R, Modi TG, et al. Oral cancer: etiology and risk factors: a review. J Cancer Res Ther. 2016 Apr-Jun;12(2):458–463.
   PubMed Web of Science ®Google Scholar
• Choi S, Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res. 2008 Jan;87(1):14–32.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Kim JW, Park Y, Roh JL, et al. Prognostic value of glucosylceramide synthase and P-glycoprotein expression in oral cavity cancer. Int J Clin Oncol. 2016 Oct;21(5):883–889.
   PubMed Web of Science ®Google Scholar
• Ransohoff JD, Wei Y, Khavari PA. The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol. 2018 Mar;19(3):143–157.
   PubMed Web of Science ®Google Scholar
• Bergmann JH, Spector DL. Long non-coding RNAs: modulators of nuclear structure and function. Curr Opin Cell Biol. 2014 Feb;26:10–18.
   PubMed Web of Science ®Google Scholar
• Briggs JA, Wolvetang EJ, Mattick JS, et al. Mechanisms of long non-coding RNAs in mammalian nervous system development, plasticity, disease, and evolution. Neuron. [cited2015 Dec 2] 88(5):861–877.
   PubMed Web of Science ®Google Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. [cited2017 Oct 12]; 36(41):5661–5667.
   PubMed Web of Science ®Google Scholar
• Gao Y, Shang S, Guo S, et al. Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data. Nucleic Acids Res. [cited2021 Jan 8] 49(D1):D1251–d1258.
   PubMed Web of Science ®Google Scholar
• Zhen Q, Gao LN, Wang RF, et al. LncRNA DANCR promotes lung cancer by sequestering miR-216a. Cancer Control. 2018 Jan-Mar;25(1):1073274818769849.
   Web of Science ®Google Scholar
• Kong X, Duan Y, Sang Y, et al. LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J Cell Physiol. 2019 Jun;234(6):9105–9117.
   PubMed Web of Science ®Google Scholar
• Lei H, Gao Y, Xu X. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145. Acta Biochim Biophys Sin (Shanghai). [cited2017 Jul 1]; 49(7):588–597.
   PubMed Web of Science ®Google Scholar
• Niu Y, Ma F, Huang W, et al. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Mol Cancer. [cited2017 Jan 9] 16(1):5.
   PubMedGoogle Scholar
• Yan Z, Bi M, Zhang Q, et al. LncRNA TUG1 promotes the progression of colorectal cancer via the miR-138-5p/ZEB2 axis. Biosci Rep. [cited2020 Jun 26];40(6). 10.1042/BSR20201025.
   Google Scholar
• Ebrahimi S, Hashemy SI. MicroRNA-mediated redox regulation modulates therapy resistance in cancer cells: clinical perspectives. Cell Oncol (Dordr). 2019 Apr;42(2):131–141.
   PubMed Web of Science ®Google Scholar
• Dong L, Hong H, Chen X, et al. LINC02163 regulates growth and epithelial-to-mesenchymal transition phenotype via miR-593-3p/FOXK1 axis in gastric cancer cells. Artif Cells Nanomed Biotechnol. 2018;46(sup2):607–615.
   PubMed Web of Science ®Google Scholar
• Xie J, Wan Y, Zhang M, et al. Circ_0061825 acts as a miR-593-3p sponge to promote breast cancer progression by regulating fgfr3 expression. Cancer Manag Res. 2020;12:11243–11255.
   PubMed Web of Science ®Google Scholar
• Han W, Wang L, Zhang L, et al. Circular RNA circ-RAD23B promotes cell growth and invasion by miR-593-3p/CCND2 and miR-653-5p/TIAM1 pathways in non-small cell lung cancer. Biochem Biophys Res Commun. [cited2019 Mar 12] 510(3):462–466.
   PubMed Web of Science ®Google Scholar
• Niu X, Yang B, Liu F, et al. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression. Biomed Pharmacother. 2020 Jan;121:109623.
   PubMed Web of Science ®Google Scholar
• Zhao W, Geng D, Li S, et al. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Med. 2018 Mar;7(3):842–855.
   PubMed Web of Science ®Google Scholar
• Dhillon AS, Hagan S, Rath O, et al. MAP kinase signalling pathways in cancer. Oncogene. [cited2007 May 14] 26(22):3279–3290.
   PubMed Web of Science ®Google Scholar
• Burotto M, Chiou VL, Lee JM, et al. The MAPK pathway across different malignancies: a new perspective. Cancer. [cited2014 Nov 15] 120(22):3446–3456.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhong Q, Feng Y, et al. Long noncoding RNA TUG1 is downregulated in sepsis and may sponge miR-27a to downregulate tumor necrosis factor-α. J Int Med Res. 2020 Apr;48(4):300060520910638.
   PubMed Web of Science ®Google Scholar
• Yu L, Qu H, Yu Y, et al. LncRNA-PCAT1 targeting miR-145-5p promotes TLR4-associated osteogenic differentiation of adipose-derived stem cells. J Cell Mol Med. 2018 Dec;22(12):6134–6147.
   PubMed Web of Science ®Google Scholar
• Shuyan Liu L-HL, Wei-Wei H. Meng Wang Long noncoding RNA TUG1 regulates the development of oral squamous cell carcinoma through sponging miR-524-5p to mediate DLX1 expression as a competitive endogenous RNA. J Cell Physiol. 2019;234(11):20206–20216.
   PubMed Web of Science ®Google Scholar
• Lee S, Rauch J, Kolch W. Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci. [cited2020 Feb 7]. 21(3):1102.
   Web of Science ®Google Scholar
• Sun QY, Ding LW, Johnson K, et al. SOX7 regulates MAPK/ERK-BIM mediated apoptosis in cancer cells. Oncogene. 2019 Aug;38(34):6196–6210.
   PubMed Web of Science ®Google Scholar
• Wen S, Hou Y, Fu L, et al. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling. Cancer Lett. [cited2019 Feb 1];442:320–332.
   PubMed Web of Science ®Google Scholar
• Zou X, Blank M. Targeting p38 MAP kinase signaling in cancer through post-translational modifications. Cancer Lett. [cited2017 Jan 1]; 384:19–26.
   PubMed Web of Science ®Google Scholar
• Zhu J, Zheng Y, Zhang H, et al. Galectin-1 induces metastasis and epithelial-mesenchymal transition (EMT) in human ovarian cancer cells via activation of the MAPK JNK/p38 signalling pathway. Am J Transl Res. 2019;11(6):3862–3878.
   PubMed Web of Science ®Google Scholar